Publicacións en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (8)

2023

  1. Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals

    ACS Nano, Vol. 17, Núm. 23, pp. 23331-23346

2022

  1. U1A is a positive regulator of the expression of heterologous and cellular genes involved in cell proliferation and migration

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 831-846

2020

  1. Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Molecular Therapy - Nucleic Acids, Vol. 21, pp. 192-204

2019

  1. ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

    Molecular Therapy, Vol. 27, Núm. 11, pp. 1878-1891

2014

  1. Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine

    PLoS ONE, Vol. 9, Núm. 3

2008

  1. HLA-DR2 and white matter lesion distribution in MS

    Journal of Neuroimaging, Vol. 18, Núm. 3, pp. 328-331

2006

  1. Methylthioadenosine reverses brain autoimmune disease

    Annals of Neurology, Vol. 60, Núm. 3, pp. 323-334